<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High-grade non-Hodgkins B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is one of the principle <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> that occurs in individuals infected with the human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV-1) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">Immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that arise in immunosuppressed transplant patients have been described as both monoclonal and polyclonal, and occur in association with Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To test whether polyclonal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurred in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> we studied <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from multiple sites in three patients who died with widespread <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated large cell or large cell <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> biopsy specimens contained invasive <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cells were mature IgM-positive immunoblasts by immunohistochemical analysis, with the same B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> observed in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sites </plain></SENT>
<SENT sid="5" pm="."><plain>Only a minority of sites from <z:hpo ids='HP_0000001'>all</z:hpo> patients analyzed were monoclonal as measured by immunoglobulin gene rearrangements, with one case having several foci of monoclonal disease with other histologically identical <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> showing no evidence of monoclonal proliferation </plain></SENT>
<SENT sid="6" pm="."><plain>Similar to the transplant-associated polyclonal B-cell proliferations </plain></SENT>
<SENT sid="7" pm="."><plain>EBV gene sequences were present in multiple sites from one autopsy </plain></SENT>
<SENT sid="8" pm="."><plain>In the other two autopsies, polyclonal B-cell proliferations occurred in the absence of EBV involvement except at one site, where a minor clone of EBV-infected cells was found </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast to HIV-associated Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, no c-myc rearrangements were found at any site </plain></SENT>
<SENT sid="10" pm="."><plain>These studies describe the occurrence of polyclonal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and suggest that EBV-negative polyclonal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> may be a distinct disease entity unique to HIV-infected individuals </plain></SENT>
</text></document>